Mesoblast (ASX:MSB, Nasdaq:MESO): Commercial traction, pipeline milestones and future catalysts
Transcription of The Stock Network Interview with Mesoblast (ASX:MSB, Nasdaq:MESO), CEO and Managing Director Dr Silviu Itescu Lel Smits: Mesoblast has entered a new chapter following the launch of Ryoncil, with quarterly revenues growing and operating cash burn declining. At the same time, Mesoblast is advancing several late-stage programs across inflammatory diseases, chronic low back […]
Starpharma (ASX:SPL,US OTC:SPHRY:SPL): Leading science-led businesses with diverse & resilient teams
Transcription of The Stock Network Interview with Starpharma (ASX:SPL,US OTC:SPHRY:SPL), Chief Executive Officer Cheryl Maley Lel Smits: Starpharma is an innovative biotechnology company advancing dendrima technology to improve patient outcomes in areas including oncology. Alongside its scientific innovation, Starpharma is operating in a sector defined by long development cycles, evolving data, changing priorities and high […]
Hot, Not & Doing: BDX, IVG, KRR, COD, MEM, LTP, ORP, AEU & PEC
What’s Hot:BDX, IVG, KRR, COD, MEM, LTP, ORP, AEU & PEC What’s Not: MAY What’s Hot BDX – BCAL Diagnostics Limited today closed up 55% to finish at 9.3c on $2m stock traded. The reason they were up today was because they announced the development of BREASTEST Monitor, a new blood test for evaluating women […]
Vinyl Group (ASX:VNL) buys Pedestrian & Time Out Australia, media consolidation strategy accelerates
Transcription of The Stock Network Interview with Vinyl Group (ASX:VNL), CEO Josh Simons Lel Smits: Vinyl Group has moved to quickly reshape its media portfolio, announcing the acquisitions of Pedestrian Group and Time Out Australia within days of each other, up to purchasing Balmorgan Digital in March this year. The deals significantly expand the company’s reach […]
Pengana Private Equity Trust (ASX:PE1): Maximising mega IPOs from SpaceX to AI innovation
Transcription of The Stock Network Interview with Pengana Private Equity Trust (ASX:PE1), Investment Specialist William Dougall Lel Smits: Pengana Private Equity Trust is a diversified portfolio of institutional quality global private equity and private credit opportunities typically reserved for large institutional investors made available to Australian investors through the ASX. Following a positive May return, […]
Hot, Not & Doing: BST, VHL, X2M, PEC, LTP & OD6
What’s Hot: BST, VHL, X2M, PEC, LTP & OD6 What’s Not: ENN, KSN & LRV BST – Boresight Limited today closed up another 70% to finish at 54.5c on $6.5m stock traded. There was no news out today but yesterday they listed after raising $8m @ 20c through CPS Capital. VHL – Vitasora Health Limited today closed up 30% […]
Chariot Resources (ASX:CC9) Expands McDermitt lithium footprint as lithium market conditions improve
Transcription of The Stock Network Interview with Chariot Resources (ASX:CC9), Managing Director, Shanthar Pathmanathan Lel Smits: Chariot Resources has significantly expanded its strategic position in the McDermott Caldera after staking 573 additional claims at its Resurgent East project in Nevada, Oregon. The move nearly doubles the company’s landholding following a disciplined consolidation during the lithium […]
Ionic Rare Earths (ASX:IXR): Building a secure Western rare earth supply chain
Transcription of The Stock Network Interview with Ionic Rare Earths (ASX:IXR), Managing Director, Tim Harrison Lel Smits: Ionic Rare Earths is positioning itself at the centre of the global push for secure and sustainable rare earth supply chains through its patented magnet recycling and refining technology. The company is focused on recovering and refining critical […]
Hot, Not & Doing: T3D, OSL, VEE, VFY, ZNC & LIT
What’s Hot: T3D, OSL, VEE, VFY, ZNC & LIT What’s Not:OVT & DXN What’s Hot T3D – 333D Limited today closed up 195% to finish at 6.5c on $2.8m stock traded. The reason they were up today was because they announced a $150k investment was made in Firmus. OSL – OncoSil Medical Limited today closed up 34% to finish […]
EBR Systems (ASX:EBR): $150M raise, CMS progress & partnerships driving next phase of growth
Transcription of The Stock Network Interview with EBR Systems (ASX:EBR), Chief Corporate Development Officer, Andrew Shute Lel Smits: EBR Systems is building a fast-growing medical device company with the world’s only leadless pacemaker technology designed to improve outcomes for heart failure patients. The Silicon Valley based company’s YCRT system delivers wireless pacing directly inside the […]